4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-030337
Chief Executive Officer acquired 1,773,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Noble James Chief Executive Officer | 2019-05-16 | Option exercise | +1,773,100 | $0.14 | $253,553 | 1,773,100 | D |
Loading xslF345X03/a4.xml…